Entering text into the input field will update the search result below

NovaSure V5 global endometrial ablation device gets approval for use in Canada and Europe

Feb. 15, 2023 9:08 AM ETHologic, Inc. (HOLX)By: SA News Team
  • Hologic (NASDAQ:HOLX) said its V5 global endometrial ablation designed to treat a wide range of cervical and uterine anatomies had been approved in Canada and Europe.
  • NovaSure V5 has a cervical seal, featuring EndoForm technology, designed to increase the sealing surface and accommodate a range of cervical canals and anatomical variability.
  • The NovaSure device enables an endometrial ablation procedure for the treatment of abnormal uterine bleeding.
  • Press Release

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About HOLX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Hologic, Inc.
Sonova Holding AG
Olympus Corporation
Baxter International Inc.
Koninklijke Philips N.V.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.